Nestle (NSRGY) just rolled out a new protein shot drink that it says will help people looking to lose weight manage their hunger and naturally produce GLP-1, the hormone weight-loss drugs mimic. The U.S. Food and Drug Administration (FDA) ruled Thursday that the shortage of tirzepatide — the active ingredient in Eli…Read more...

Quartz

United States

Ozempic lures people to the doctor, Nestle's GLP-1 'shot,' an FDA Zepbound ruling: Pharma news roundup

Specialist surgeons don't think that medications like Ozempic will replace surgery.

Les chirurgiens spécialistes ne pensent pas que les médicaments comme Ozempic vont remplacer l’opération.

La chirurgie bariatrique ne sera pas remplacée par les médicaments comme Ozempic, pensent des médecins

Media Bias/Fact Check

TVA Nouvelles

Montreal

Quebec

Canada

Bariatric surgery won't be replaced by drugs like Ozempic, doctors think

The European Union's Medicines Agency is expected to review two studies that found a rare eye disease that could cause blindness among Ozempic users. The manufacturer claims in response: "The drug's benefits outweigh the drawbacks."

רשות התרופות של האיחוד האירופי צפוי לבחון שני מחקרים שמצאו בקרב משתמשי אוזמפיק מחלת עיניים נדירה העלולה לגרום לעיוורון. היצרנית טוענת בתגובה: "יתרונות התרופה עולים על החסרונות"

בדיקה: האם זריקת הפלא להרזייה אוזמפיק עלולה לגרום לעיוורון?

Maariv Online

Israel

Test: Can the miracle weight loss shot Ozempic cause blindness?

Ophthalmologists at Harvard Medical School and Mass Eye and Ear, a teaching hospital in Boston, found evidence that the active ingredient in weight loss miracle drugs like Ozempic and Wegovy, semaglutide, could, in rare cases, cause blindness.  Now, two different teams of researchers from the University of Southern Denmark released studies backing up the findings of Harvard Medical School’s ophthalmologists. All three studies showed a link betwe…

Ad Fontes Media

All Sides

Vice

The Walt Disney Company

TPG Capital

Hearst Communications

Shane Smith (journalist)

Soros Fund Management

James Murdoch

New York

Ozempic Could Be Blinding People Trying to Lose Weight

European Drug Regulators Investigating Semaglutide-Related NAION Cases Presented in Two Danish Studies   (Posted by Tom Lamb at Drug Injury Watch)   According to this December 18, 2024, Reuters news report, “Novo Nordisk’s Ozempic faces EU review for potential eye disease connection“, there is a significant development concerning semaglutide weight-loss drugs like Ozempic linked to vision loss and blindness: 
The European Union’s drug regulator …

LexBlog

Semaglutide Weight-Loss Drugs Like Ozempic Linked to Vision Loss: December 2024 Update

The ever-increasing use of GLP-1 agonists is uncovering clues about what else they can do.

MIT Technology Review

Boston

Suffolk County

Massachusetts

Drugs like Ozempic now make up 5% of prescriptions in the US

Semaglutide belongs to a class of medicines known as agonists, which are responsible for stimulating insulin release by the pancreas, a hormone crucial for reducing blood glucose levels. It also promotes the growth of pancreatic beta cells, which are responsible for the production and release of insulin. Semaglutide also inhibits the production of glucagon, a hormone that promotes the release of carbohydrates stored in the liver and the synthesi…

La semaglutida pertenece a una clase de medicamentos conocidos como agonistas, que se encargan de estimular la liberación de insulina por el páncreas, una hormona crucial para reducir los niveles de glucosa en la sangre. Además, fomenta el crecimiento de las células beta pancreáticas, que son las responsables de la producción y liberación de insulina. La semaglutida también inhibe la producción de glucagón, una hormona que promueve la liberación…

Ozempic lures people to the doctor, Nestle's GLP-1 'shot,' an FDA Zepbound ruling: Pharma news roundup

Coverage Details

Give the gift of Perspective

Bias Distribution

Ownership

Similar News Topics

Similar News Topics